HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elias Campo Selected Research

Endoplasmic Reticulum Chaperone BiP

11/2011The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma.
1/2011The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elias Campo Research Topics

Disease

82Neoplasms (Cancer)
01/2024 - 01/2002
41Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2024 - 01/2002
35Lymphoma (Lymphomas)
03/2024 - 03/2002
29Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2023 - 06/2002
23B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2023 - 09/2002
13B-Cell Lymphoma (Lymphoma, B Cell)
03/2023 - 06/2004
10Disease Progression
01/2021 - 11/2004
7Burkitt Lymphoma (Burkitt's Lymphoma)
01/2016 - 06/2006
6Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
05/2014 - 04/2002
5Leukemia
01/2018 - 06/2004
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018 - 01/2007
4Trisomy (Trisomies)
12/2021 - 01/2018
4Genetic Translocation (Chromosomal Translocation)
03/2008 - 01/2005
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 06/2013
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021 - 02/2014
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2019 - 02/2002
3Ataxia Telangiectasia (Louis Bar Syndrome)
11/2011 - 01/2002
3Chromosomal Instability (Chromosome Stability)
10/2008 - 12/2002
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 06/2004
2Carcinogenesis
01/2024 - 10/2012
2T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
01/2022 - 01/2020
2Multiple Myeloma
01/2021 - 01/2020
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2017 - 02/2013
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017 - 10/2010
2Sarcoma (Soft Tissue Sarcoma)
01/2017 - 01/2016
2Carcinoma (Carcinomatosis)
11/2006 - 11/2005
1Hematologic Neoplasms (Hematological Malignancy)
05/2024

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
05/2024 - 01/2002
13Rituximab (Mabthera)FDA Link
10/2023 - 01/2011
13Cyclin D1IBA
01/2021 - 02/2003
10Messenger RNA (mRNA)IBA
01/2017 - 12/2002
9Biomarkers (Surrogate Marker)IBA
10/2023 - 03/2007
9Phosphotransferases (Kinase)IBA
12/2021 - 01/2002
9CyclinsIBA
01/2021 - 12/2005
9ParaffinIBA
01/2018 - 10/2008
8Immunoglobulins (Immunoglobulin)IBA
01/2023 - 03/2002
7DNA (Deoxyribonucleic Acid)IBA
02/2014 - 06/2002
6MicroRNAs (MicroRNA)IBA
01/2022 - 09/2008
6Formaldehyde (Formol)FDA Link
01/2018 - 06/2011
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2017 - 09/2002
6Anaplastic Lymphoma KinaseIBA
05/2014 - 04/2002
5ChromatinIBA
01/2021 - 01/2017
5AntigensIBA
01/2019 - 02/2002
5fludarabineIBA
04/2017 - 09/2002
5Bortezomib (Velcade)FDA Link
02/2013 - 01/2006
4AntibodiesIBA
01/2014 - 03/2002
4Prednisone (Sone)FDA LinkGeneric
10/2012 - 11/2011
4Vincristine (Oncovin)FDA LinkGeneric
10/2012 - 11/2011
4Doxorubicin (Adriamycin)FDA LinkGeneric
10/2012 - 11/2011
4Cyclin D2IBA
11/2009 - 02/2004
4Pyridinolcarbamate (P23)IBA
01/2005 - 04/2002
3Bendamustine HydrochlorideFDA Link
10/2023 - 11/2008
3ibrutinibIBA
12/2020 - 09/2015
3LigandsIBA
12/2019 - 11/2004
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2019 - 09/2004
3Transcription Factors (Transcription Factor)IBA
01/2018 - 06/2009
3Lenalidomide (CC 5013)FDA Link
01/2018 - 10/2010
3Mitoxantrone (Novantrone)FDA LinkGeneric
04/2017 - 09/2002
3NucleosidesIBA
08/2015 - 07/2006
3Cytidine DeaminaseIBA
06/2015 - 07/2006
3RNA (Ribonucleic Acid)IBA
02/2014 - 08/2010
3Proteasome InhibitorsIBA
11/2011 - 01/2006
3Immunoglobulin M (IgM)IBA
01/2010 - 03/2002
3NF-kappa B (NF-kB)IBA
04/2009 - 06/2006
3NucleophosminIBA
01/2005 - 08/2004
2HLA-B Antigens (HLA-B)IBA
03/2024 - 03/2023
2Protein Isoforms (Isoforms)IBA
12/2022 - 06/2007
2CytokinesIBA
12/2021 - 01/2019
2ChemokinesIBA
12/2021 - 01/2018
2Agammaglobulinaemia Tyrosine KinaseIBA
12/2021 - 11/2017
2venetoclaxIBA
12/2020 - 08/2015
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020 - 06/2013
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2020 - 01/2019
2Chemokine ReceptorsIBA
01/2019 - 01/2017
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2019 - 02/2011
2ElementsIBA
01/2018 - 03/2013
2Chlorambucil (Leukeran)FDA Link
06/2017 - 02/2013
2carboxyl radical (COO-)IBA
02/2014 - 06/2011
2Monoclonal AntibodiesIBA
01/2014 - 08/2011
2SOXC Transcription FactorsIBA
03/2013 - 11/2009
2Endoplasmic Reticulum Chaperone BiPIBA
11/2011 - 01/2011
2Tyrosine (L-Tyrosine)FDA Link
12/2010 - 08/2004
2I-kappa B KinaseIBA
04/2009 - 02/2007
2Adenosine Monophosphate (AMP)IBA
10/2008 - 06/2006
2Antigen Receptors (Antigen Receptor)IBA
03/2008 - 07/2006
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2006 - 03/2003
2Complementary DNA (cDNA)IBA
09/2005 - 01/2004
1Aspartic Acid (Aspartate)FDA Link
05/2024
1triphosphoric acid (triphosphate)IBA
05/2024
1CTPaseIBA
05/2024
1Histidine (L-Histidine)FDA Link
05/2024
1Cytarabine (Cytosar-U)FDA LinkGeneric
05/2024
1AntioxidantsIBA
01/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024
1Immune Checkpoint InhibitorsIBA
11/2023
1TrihalomethanesIBA
09/2023

Therapy/Procedure

29Therapeutics
01/2024 - 02/2003
10Drug Therapy (Chemotherapy)
01/2019 - 06/2002
2Precision Medicine
11/2022 - 01/2022
2Stem Cell Transplantation
06/2006 - 02/2002